期刊
JOURNAL OF VIROLOGY
卷 89, 期 16, 页码 8651-8656出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.00614-15
关键词
-
类别
资金
- German Center for Infection Research (DZIF) [TTU 01.802, TTU 01.904]
- Deutsche Forschungsgemeinschaft [SFB1021]
Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory disease in humans. We tested a recombinant modified vaccinia virus Ankara (MVA) vaccine expressing full-length MERS-CoV spike (S) glycoprotein by immunizing BALB/c mice with either intramuscular or subcutaneous regimens. In all cases, MVA-MERS-S induced MERS-CoV-specific CD8(+) T cells and virus-neutralizing antibodies. Vaccinated mice were protected against MERS-CoV challenge infection after transduction with the human dipeptidyl peptidase 4 receptor. This MERS-CoV infection model demonstrates the safety and efficacy of the candidate vaccine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据